acute myeloid leukemia, FLT3 tyrosine kinase domain point mutation

Acute myeloid leukemia, FLT3 tyrosine kinase domain point mutation is a type of blood cancer. It is defined by a specific mutation in the FLT3 gene where a single nucleotide change occurs in the tyrosine kinase domain. This mutation is linked with the development of acute myeloid leukemia and is known to be associated with a poor prognosis. People with this condition have leukemia that is characterized by this FLT3 point mutation. The mutation affects how the gene works, leading to abnormal cell growth. The summary provided here is based on the provided definition and emphasizes the genetic nature of this abnormality.

Information about symptoms is currently limited for this condition.

This condition is caused by a single nucleotide mutation in the FLT3 gene. The mutation occurs in the tyrosine kinase domain, which plays an important role in cell growth and survival. This genetic anomaly is directly linked to the development of acute myeloid leukemia.

Information about treatment is currently limited for this condition.

The mutation in the FLT3 gene is associated with a poorer outlook compared to other forms of acute myeloid leukemia. This means that the disease can be more aggressive. However, the exact quality of life and long term outcomes can vary, and details are limited in the available information.

Information about current research is currently limited for this condition.